IP Library Granted Patent US 11,041,859
Granted Patent B2
US 11,041,859 · App. 15/783,423 · Granted Jun 22, 2021

Methods of identifying SENP1 inhibitors

Inventors: Yuan Chen (Arcadia, CA); Chih-Hong Chen (Duarte, CA); Andrew Namanja (Duarte, CA)
Assignee: CITY OF HOPE
G01N33/573G01N2440/36G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,041,859
App. No.
15/783,423
Granted
Jun 22, 2021
Kind
B2
Abstract

Provided herein are methods of detecting binding of an SENP1 polypeptide to a compound and methods for screening for inhibitors of SENP1. Further provided are aqueous compositions comprising SENP1 polypeptides and NMR apparatuses comprising the compositions for NMR analysis.

Claims (12)

1. A method of screening for a binding compound of sentrin/SUMO-specific protease 1 (SENP1) comprising contacting a composition comprising an SENP1-small-ubiquitin-like modifier (SUMO) complex with a test compound and detecting whether the test compound binds SENP1 or a fragment thereof by nuclear magnetic resonance.

2. The method of claim 1 , wherein the detecting comprises determining a chemical shift for an amino acid in an active site of SENP1.

3. The method of claim 2 , wherein the chemical shift in the presence of the compound is changed relative to the corresponding chemical shift in the absence of the compound.

4. The method of claim 3 , wherein the amino acid is selected from the group consisting of an amino acid residue corresponding to D550, H533, C603, W465, W534, L466, G531, C535, M552, G554, E469, and Q596 of SEQ ID NO:1.

5. The method of claim 1 , wherein SENP1 comprises SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.

6. The method of claim 1 , wherein SENP1 comprises a mutation at an amino acid residue corresponding to amino acid residue 603 of SEQ ID NO:1.

7. The method of claim 1 , wherein the detecting comprises producing an NMR spectra of a SENP1-SUMO-compound complex and identifying a change in the NMR spectra relative to the absence of the compound.

8. The method of claim 7 , wherein the change is a change in the chemical shift of an amino acid of SEQ ID NOs: 3, 4, 5, 6 or 7.

9. The method of claim 7 , wherein the change is a change in the chemical shift of the amino acid corresponding to the amino acid C603 of SEQ ID NO:1.

10. The method of claim 7 , wherein the change is a change in the chemical shift of an amino acid residue 440-455, 463-473, 493-515, 529-535, 550-554, or 596-603 of SEQ ID NO:1.

11. The method of claim 1 , further comprising a biochemical assay.

12. The method of claim 11 , wherein the biochemical assay is an enzyme kinetics assay, gel based assay, bioluminescent assay, or fluorescent assay.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: NAMANJA, ANDREW; CHEN, YUAN; CHEN, CHIH-HONG
To: CITY OF HOPE
Reel/Frame 056277/0723 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: CHEN, YUAN
To: CITY OF HOPE
Reel/Frame 056277/0748 →
Continuity (4)
Division 14247153 · Apr 7, 2014
Provisional Application 61813832 · Apr 19, 2013
Provisional Application 61809208 · Apr 5, 2013
Related Publication 20180143196A1 · May 24, 2018